Clinical Trial Update: Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating donepezil in female breast cancer survivors with cognitive dysfunction has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cognition Disorders

Drugs mentioned

• Donepezil (donepezil)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Anxiety Disorder, Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-01-09